Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer
Daniel Brungs(University of Wollongong), Marie Ranson(University of Wollongong), Morteza Aghmesheh(New South Wales Department of Health), Jay R. Perry(University of Wollongong), Moeava Tehei(Institut Laue-Langevin), Kara L. Vine(University of Wollongong), Shantay Ryan(Liverpool Hospital), Therese M. Becker(Liverpool Hospital), Ann‐Katrin Piper(The University of Sydney), Elahe Minaei(University of Wollongong), Ashleigh Splitt(Wollongong Hospital), Stéphanie Corde(University of Wollongong), Xiao Wu(Liverpool Hospital), Martin Carolan(University of Wollongong)
Cited by 50
Related Papers
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
|Journal of Controlled Release|2018|297
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|Anti-Cancer Agents in Medicinal Chemistry|2009|269
Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook
|Advanced Materials|2018|217